Gregory Conko, a senior fellow at the Competitive Enterprise Institute, comments on the GlaxoSmithKline settlement where the pharmaceutical company agreed to pay a record $3 billion in fines to settle various criminal and civil charges associated with 10 of the company's drugs -- making this the largest such settlement in history.
Greg Conko: GSK to pay $3 billion; FDA's "debarment trap" strikes again
Related Entries:
- California's Prop 65: A vehicle for large attorney's fees
- Medical malpractice reform in New Hampshire
- Manhattan Institute Event: Overcriminalizing the Empire State?
- James Copland on overcriminalization: NY prosecutors have too much power
- A 12 Step Program For Overcriminalization
- Hans Bader on double jeopardy safeguards: Blueford v. Arkansas
- New Podcast: John Edwards prosecution
- James Copland: Justice Department may be in the next cubicle
- The John Edwards trial: "Cad Example"
- Arbitrary campaign finance prosecution department
- Around the web, May 11
- Around the web, May 10
- Paul Larkin responds to FOCUS Act critiques
- Around the web, May 7
![]() |
| Isaac Gorodetski Project Manager, Center for Legal Policy at the Manhattan Institute igorodetski@manhattan-institute.org |
![]() |
| Laura Eyi Press Officer, Manhattan Institute leyi@manhattan-institute.org |




Leave a comment
Once submitted, the comment will first be reviewed by our editors and is not guaranteed to be published. Point of Law editors reserve the right to edit, delete, move, or mark as spam any and all comments. They also have the right to block access to any one or group from commenting or from the entire blog. A comment which does not add to the conversation, runs off on an inappropriate tangent, or kills the conversation may be edited, moved, or deleted.
The views and opinions of those providing comments are those of the author of the comment alone, and even if allowed onto the site do not reflect the opinions of Point of Law bloggers or the Manhattan Institute for Policy Research or any employee thereof. Comments submitted to Point of Law are the sole responsibility of their authors, and the author will take full responsibility for the comment, including any asserted liability for defamation or any other cause of action, and neither the Manhattan Institute nor its insurance carriers will assume responsibility for the comment merely because the Institute has provided the forum for its posting.